(Q35586820)

9 August 2017

1 reference

title

Steroid sulphatase inhibitors for breast cancer therapy (English)

1 reference

9 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00353-4

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00353-4

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00353-4

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00353-4

3 April 2024

author name string

A. Purohit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

L. W L. Woo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

S. K. Chander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

S. P. Newman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

C. Ireson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

Y. Ho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

A. Grasso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

M. P. Leese

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

B. V L. Potter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

M. J. Reed

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623540

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623540

3 April 2024

publication date

1 September 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S0960076003003534?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00353-4

https://api.elsevier.com/content/article/PII:S0960076003003534?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00353-4

The Journal of Steroid Biochemistry and Molecular Biology

3 April 2024

published in

1 reference

9 August 2017

volume

86

1 reference

9 August 2017

issue

3-5

1 reference

9 August 2017

page(s)

423-432

1 reference

Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Steroid sulfatase in the human hair follicle concentrates in the dermal papilla

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Control of aromatase activity in breast tumours: the role of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Steroid sulfation Current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Steroid sulfotransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Importance of estrogen sulfates in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Estrone sulfate: production rate and metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Elevated steroid sulfatase expression in breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

The interrelationship between plasma 5-ene adrenal androgens in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Sulfate derivatives of 2-phenylindoles as novel steroid sulfataseinhibitors. An in vitro study on structure-activity-relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Regulation and inhibition of steroid sulfatase activity in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Development of potent non-estrogenic estrone sulfatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Non-steroidal and steroidal sulfamates: new drugs for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Novel oestrogen sulfamates: a new approach to oral hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Recent advances in the development of steroid sulphatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Inhibition of human estrogen synthetase (aromatase) by flavones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Flavonoid inhibition of aromatase enzyme activity in human preadipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

The production and aromatization of dehydroepiandrosterone in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900353-4

7 January 2021

A carbonic anhydrase inhibitor as a potential modulator of cancer therapies

52

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00353-4

3 April 2024

Identifiers

1 reference

9 August 2017

1 reference